Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plenum Bioengenharia is a Brazilian biotechnology company focused on the development of innovative biomaterials for bone regeneration and tissue engineering. Based in Jundiaí, the company produces high-tech synthetic bone substitutes, membranes, and surface treatments for dental and orthopedic implants. Their core technology involves the production of pure synthetic hydroxyapatite, which offers high biocompatibility and predictable clinical outcomes without the risks associated with animal-derived materials. Plenum's product portfolio includes Plenum Oss, a synthetic bone graft, and Plenum Guide, a collagen-based membrane. The company maintains strong ties with academic institutions to validate its regenerative solutions through clinical research. Plenum aims to expand its footprint in the global regenerative medicine market by providing sustainable and effective synthetic alternatives to traditional grafting methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plenum Bioengenharia.